managing acute pain for hospitalized patients with ... · transition to bupe at initiation continue...
TRANSCRIPT
![Page 1: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/1.jpg)
Managing Acute Pain for Hospitalized Patients with Substance Use Disorder
Jane Liebschutz MD MPH @Liebschutz
Update in Internal MedicineOctober 10, 20191
![Page 2: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/2.jpg)
2
Patient: SS 47 yo female
Consult: Help with pain management
HPI:Presented after accidental heroin OD with compartment syndrome, rhabdomyolysis s/p fasciotomies
![Page 3: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/3.jpg)
3
Patient: JB 29 year old male
HPI:Admitted for AVR, MVR for fungal endocarditis to native valves dx’d in April 2019 Treated oral fluconazole; Worsening CV function CHF
Consult: Pain management and transition to buprenorphine
![Page 4: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/4.jpg)
4
Patient: LR 39 year old male
HPI:Admitted for R shoulder pain. Blood cultures + for MSSALeft AMA b/c pain not controlled at OSHPresented to Presby ED
Consult: Help with addiction
![Page 5: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/5.jpg)
Learning Objectives
• Describe a framework for acute pain management in the context of opioid use disorder
• Institute best practices for managing acute pain in patients maintained on buprenorphine
• Learn a novel method to switch from full opioid agonists to buprenorphine
![Page 6: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/6.jpg)
Addiction Is a Brain Disease
• Drugs hijack brain reward circuits
• Develop tolerance and withdrawal
• Learned behavior “Habit”
THE OPIOID EPIDEMICVolkow, N Engl J Med 2016; 374:363-371 Lewis, N Engl J Med 2018; 379:1551-1560
![Page 7: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/7.jpg)
77https://smhsgwu.hosted.panopto.com/Panopto/Pages/Viewer.aspx?tid=88dcb04f-b129-4b94-9baf-5e34e8683f65
![Page 8: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/8.jpg)
Opioid Use Disorder
(OUD) Symptoms
8
Strong desire for opioids
Inability to control or reduce use
Continued use despite harm
Tolerance/Use of larger amounts over time
Spending a great deal of time to obtain & use opioids
Withdrawal symptoms
![Page 9: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/9.jpg)
Increased vulnerabilities
impact experience of
pain
9
Experience of Pain
Pain threshold
Social Stress
Depression-Anxiety
Financial Strain
Coping Skills
Liebschutz,2014, Current Treatment Options in Psychiatry
![Page 10: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/10.jpg)
Pain impacts recovery from
SUD
Pain
Distress
Craving
Use
Withdrawal
10
![Page 11: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/11.jpg)
Goals of care
11
Humane care
Standard medical treatmentPrevention of withdrawal
Alleviate acute painSubstance use –discussion/referral
Initiate MOUD
Linkage to Treatment
![Page 12: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/12.jpg)
12
Humane care
Non-stigmatizing language
Person who uses drugs PWUDPerson who injects drugs PWID
Impacts clinical care and treatment
decisions
Erodes confidence that addiction is a valid and treatable
health condition
Stigma
Van Boekel 2013 DAD
![Page 13: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/13.jpg)
Patient: SS 47 yo female
13
HPI:Presented after accidental heroin OD with compartment syndrome, rhabdomyolysis s/p fasciotomies
Past Medical HistoryDepressionHep C (treated)Past Substance Use HistoryHeroin- return to drug use after OD death of daughterCocaine- crack, intermittentInjection Drug use
![Page 14: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/14.jpg)
14
Case: Fasciotomies, Untreated OUD, Depression
Clinical question: Pain control and OUD
Multiple surgeries on RLE
Pt c/o pain post-op
PCA Pump:
No Basal; Hydromorphone 1 mg bolus 4x/hr 4x12= 48 mg
Hydromorphine 3 mg IVP q 6 hours 3 x4=12 mg
Humane
Medical Rx
Withdrawal
Acute pain
![Page 15: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/15.jpg)
What option would you choose next for her treatment?
1. Methadone for both opioid withdrawal and pain2. Buprenorphine for both opioid withdrawal and pain3. Start to taper the medications so she won’t be
dependent at discharge4. Add basal dose hydromorphone
15
![Page 16: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/16.jpg)
Methadone
Mechanism of actionqAgonist at the mu
receptor. qActs in the CNS and
smooth muscleqForms: Oral, Injectable
16
![Page 17: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/17.jpg)
PharmacokineticsqLong and variable half-life for sedation,
withdrawalqOpioid-naive half life: 55+ hoursqOpioid-tolerant half-life 24 hours
qMethadone analgesia 4-8 hours
17
Grissinger 2011 P & T
![Page 18: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/18.jpg)
Cardiac risksqQT prolongation >500 ms:
q2-16% of patients on methadoneqMortality rate for cardiac arrhythmia attributable
to methadone 0.06 per 100 patient-years
18
Pani 2013 Cochrane review
![Page 19: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/19.jpg)
Long term methadoneqFederally licensed programsqDaily dosingqBarriers: transportation, time, stigma
19
Pani 2013 Cochrane review
![Page 20: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/20.jpg)
BuprenorphineqMechanism of action
qPartial agonistic effect at the mu-opioid receptors
qBinds 16x more tightly than morphine
qHalf-life 24-42 hoursq Forms
qSublingualq InjectionqTransdermalq Implant
May Precipitate Withdrawal
![Page 21: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/21.jpg)
Office Based Buprenorphine
21
First Office Based MOUD treatment
The Drug Addiction Treatment Act of 2000 • 8 hour training to qualify physicians for a waiver
to prescribe and dispense buprenorphine (24 hrs for NP/PA)
American Society of Addiction Medicine (ASAM)• Free courses- online and live
![Page 22: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/22.jpg)
22
Kosten, O’Connor. NEJM. 2003.
Withdrawal Symptom Severity
![Page 23: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/23.jpg)
Inpatient Prescribing
Rules
23
If opioid use disorder is complicating inpatient medical treatment, no need for special
waiver to prescribe:
• Methadone 20-40 mg/day• Buprenorphine 2-16 mg/day
• Needs to be in withdrawal or opioid free
![Page 24: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/24.jpg)
What option would you
choose next for her treatment?
1. Methadone for both opioid withdrawal and pain
2. Buprenorphine for both opioid withdrawal and pain
3. Start to taper the medications so she won’t be dependent at discharge
4. Add basal dose hydromorphone
24
![Page 25: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/25.jpg)
Theoretical Concern with IR/SA Opioids
With
draw
al Pain Pain Pain Pain
Opioid Opioid Opioid Opioid
Incre
ased
Side e
ffects
Com
fort
Opi
oid
Conc
entr
atio
n
Opioid Withdrawal-Mediated Pain
![Page 26: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/26.jpg)
What’s a MME?
• Morphine Milligram Equivalent– Tested on normal controls in laboratory conditions
• Caution when calculatingHydromorphone: 48 + 18 = 60 mg/dayConversion to Morphine = 1200 MME/day
26
![Page 27: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/27.jpg)
What we did
Basal Hydromorphone 0.5 mg/hour = 12 mg/day
Bolus: 0.5 mg every 20 minutes = 36 mg/day
Start LA Oral Morphine 15 mg bid
Stop IV Push
Motivational Interviewing for MOUD
27
Markedly improved painStarting point for tapering
![Page 28: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/28.jpg)
Patient: JB 29 year old male
28
HPI:Admitted for AVR, MVR for fungal endocarditis to native valves dx’d in April 2019 Treated oral fluconazole; Worsening CV function CHF
Past Substance Use History
Heroin, stopped ~7 years ago when started on bupe;
Failed tapering à Injection drug use in December- March 2019 àendocarditis
Stable on bupe/naltrexone 16 mg/day
![Page 29: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/29.jpg)
Buprenorphine & Surgery Option 1
29
Continue bupe throughout perioperative period
Add non-opioid pain treatments
Add IV opioids as needed
![Page 30: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/30.jpg)
Buprenorphine & Surgery Option 2
30
Hold bupe morning of procedure
LA/ER opioid for basal dose (Morphine 15 bid)
PCA for breakthrough
Transition to bupe post-discharge
![Page 31: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/31.jpg)
Buprenorphine & Major
Surgery Option 3
31
Stop bupe >5 days prior to surgery
LA/ER opioid for withdrawal (Morphine 15 bid)
PCA for breakthrough perioperatively
Transition to bupe post-discharge
NOTE- RISK FOR RELAPSE HIGH OFF BUPE
![Page 32: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/32.jpg)
Patient: AVR/MVR
post-op pain
32
Hydromorphone 3 mg IV q 4 hours prn
Significant pain
![Page 33: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/33.jpg)
Pharmacodynamics-IV Hydromorphone
33
ONSET- 5 MIN PEAK- 10-20 MIN
HALF-LIFE ~3 HOURS
![Page 34: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/34.jpg)
What we did
initially
34
Start LA Oral Morphine 15 mg bid (standing)
Oral oxycodone 20 mg every 4 hours (standing)
Hydromorphone 0.5 mg IV Push q3 hours for severe pain x 48 hours
![Page 35: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/35.jpg)
Non-Opioid Pain Options: NSAIDS
35
Does Multimodal Analgesia with Acetaminophen, Nonsteroidal Antiinflammatory Drugs, or Selective Cyclooxygenase-2 Inhibitors and Patient-controlled Analgesia Morphine Offer Advantages over Morphine Alone?:Meta-analyses of Randomized Trials Anesthes. 2005;103(6):1296-1304. doi:0000542-200512000-00025
24 hr morphine consumption, weighted mean difference
![Page 36: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/36.jpg)
Ketamine (Off label
use for pain)Non competitive reversible
inhibitor of NMDA receptor, acts on mu opioid receptor.
Impact on pain at rest over 24 hrs
36
![Page 37: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/37.jpg)
Ketamine (Off-label
use for pain)
37
Impact on weighted mean difference in morphine use over
24 hrs
![Page 38: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/38.jpg)
Gabapentinoids
38
Limited evidence shows some benefit
High rates of sedation and dizziness
Potential drug of abuse with street value
DO NOT START LONG TERM TREATMENT FOR ACUTE PAIN
![Page 39: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/39.jpg)
Transition to bupeAt initiation Continue short acting opioid regimenDay 1 Add ButransTM 20 mcg/hr patch (10 mcg/hr patch if MME 30-80/day)
Day 2 Start buprenorphine 1 mg sl, observe 2 hrs
If pain or withdrawal, administer 1-2 mg sl, observe 2 hrs
Repeat above up to buprenorphine 8 mg
Discontinue ButransTM patch
Day 3 Administer Day #2 buprenorphine dose
If pain or withdrawal, can titrate up to buprenorphine 16 mg/day
Day 4 Administer Day #3 buprenorphine dose
If pain or withdrawal, can titrate up to 24 mg/day
Consider split dosing of buprenorphine for pain management
Day 5 Continue established daily bupe dose. Taper/Discontinue other opioids
as appropriate39
![Page 40: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/40.jpg)
40
Patient: LR 39 year old male
HPI:
Admitted for R shoulder pain. Blood cultures + for MSSA
Left AMA b/c pain not controlled at OSH
Presented to Presby ED
Past Substance Use History
Heroin, since age 20
Crack cocaine
Periods of sobriety without any meds, +12-step meetings
XR-naltrexone (Vivitrol)
![Page 41: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/41.jpg)
Case: Septic Shoulder,
Endocarditis, Untreated Addiction
41
Behavioral- leaving AMA
Pain
Interested in naltrexone treatment
![Page 42: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/42.jpg)
Plan
42
Behavioral: • Build trust• Make alliance with patient
Pain:• Standing pain regimen,
including long acting
![Page 43: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/43.jpg)
Conversion to naltrexone• Opioid antagonist• Need 7 days off all opioids
43
![Page 44: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/44.jpg)
XR-NTX vs. Buprenorphine
44 Lee 2018 The Lancet
USA n=570XR-NTX 72% inductionBup-NX 94% induction
XR naltrexone vs. buprenorphine/naltrexone
![Page 45: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/45.jpg)
Management
45
SUPPORTIVE CARE ALLIANCE WITH PATIENT
RESIDENTIAL OR CLOSE FOLLOW UP
![Page 46: Managing Acute Pain for Hospitalized Patients with ... · Transition to bupe At initiation Continue short acting opioid regimen Day 1 Add ButransTM 20 mcg/hrpatch (10 mcg/hrpatch](https://reader035.vdocument.in/reader035/viewer/2022070801/5f02a4ce7e708231d4054a93/html5/thumbnails/46.jpg)
Learning Objectives
• Describe a framework for acute pain management in the context of opioid use disorder
• Institute best practices for managing acute pain in patients maintained on buprenorphine
• Learn a novel method to switch from full opioid agonists to buprenorphine